When do you consider low-dose buprenorphine for the management of treatment resistant depression?
How have you prescribed it and if so what dosing strategy? Where does it fall on your pharmacologic approach to treatment resistant depression?
Community PollStarted
Have you ever used buprenorphine in the management of difficult-to-treat depression?
27 physicians have voted
Join Mednetto vote and see how they answered.
2 Answers
Mednet MemberInvited Expert
Psychiatry · Perelman School of Medicine, University of Pennsylvania
Answered on
At doses of 0.25-2 mg, buprenorphine has potent kappa opioid receptor antagonism, and this conveys anxiolytic and antidepressant activities. It can be used in an augmentation mode with other antidepressants. See (Karp et al., PMID 25191915; Fava et al., PMID 26869247; Thase et al., PMID 31254971; Fa...
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Psychiatry · Perelman School of Medicine, University of Pennsylvania
Answered on
Because of the potential for nausea/vomiting, it is important to give a test dose of 0.25 mg daily orally. If that is tolerated over a week, increase to 0.5 mg daily for a week, then 1 mg daily, depending on response.
Join for free or sign in to see the full answer